Metraipolis › archive › dc_df832e9972ef

Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination — Europe PMC PMID:41288098

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41288098
DOI
10.1128/mbio.02901-25
License (as archived)
solo-consultazione
Archived
2026-11-08T07:01:40.983Z
SHA-256 of the archived text
8f050caf3e9f9ce40dc5136df4e4e28e7cc249514229ab86e43d4b3e3e5c6f6e
Stable URL of this page
https://metraipolis.com/documento/dc_df832e9972ef

How to cite

Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination — Europe PMC PMID:41288098 — Europe PMC (en), https://europepmc.org/article/MED/41288098 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df832e9972ef (Metraipolis archive dc_df832e9972ef, sha256 8f050caf3e9f9ce40dc5136df4e4e28e7cc249514229ab86e43d4b3e3e5c6f6e)
BibTeX
@misc{dcdf832e9972ef,
  title = {Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination — Europe PMC PMID:41288098},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41288098},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df832e9972ef; sha256 8f050caf3e9f9ce40dc5136df4e4e28e7cc249514229ab86e43d4b3e3e5c6f6e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41288098. Agents can read the archived copy with the MCP tool read_document.